From Ultra Rapid to Ultra Long: The Role of Newer Insulins in Diabetes Management Home Study

ACPE UAN #:  0233-9999-16-037-H01-P

Release Date: April 21, 2016

Expiration Date:  April 20, 2019

Activity Type:  Knowledge-based  

Contact Hours:  2.0 

Activity Fee:  Member:  FREE -   Non-Member: FREE 

Program Description 

The diabetes treatment armamentarium includes a growing number of insulin analogs designed to mimic normal basal insulin secretion and prandial insulin response as precisely as possible.  With more insulin products on the market than ever before—and others, including biosimilar insulin, on the way—the inevitable questions arise: what is the optimal role of these products in the care of patients with diabetes?  What benefits do newer insulins provide, and what value can they offer?  This symposium will provide an in-depth review of new and emerging insulin products, with a focus on considerations most germane to rational formulary decision-making.  You will leave with an improved ability to evaluate the cost-effectiveness of insulin therapy. 

Target Audience  

This knowledge-based activity has been designed to meet the educational needs of pharmacists, physicians, and nurses practicing in managed care settings.

Learning Objectives   

At the completion of this activity, participants should be able to:   

  1. Explain how the growing spectrum of insulin products strives to replicate physiological insulin secretion with minimal hypoglycemia and maximal patient convenience.
  2. Summarize information pertinent to formulary evaluation of new and emerging insulin products, including clinical efficacy, safety, and potential benefits relative to existing products.
  3. Discuss the role of insulin therapy in the management of type 1 and type 2 diabetes, as outlined in current clinical practice guidelines.
  4. Identify specific advantages of new and emerging insulin products that could have a positive impact on patient care and diabetes-related quality measures.
  5. Recognize potential challenges associated with the use of new and emerging insulin products.   

Schedule of Educational Activity

  1. Diabetes and Insulin Overview:  Dr. Sarah Kim, MD
  2. New Options in Insulin Therapy:  Dr. Amy M. Lugo, PharmD, BCPS, BC-ADM, FAPhA
  3. Safety and Tolerability:  Dr. Amy M. Lugo, PharmD, BCPS, BC-ADM, FAPhA
  4. Insulin use in Clinical Practice:  Dr. Sarah Kim, MD  
Faculty Disclosures

Joint Providership  

This activity is presented jointly by the Academy of Managed Care Pharmacy and PRIME® Education, Inc.

        AMCP Logo       Prime Logo


As an ACPE-accredited provider, AMCP strictly adheres to the ACPE Standards for Commercial Support and other relevant guidelines and standards to ensure the independence of CPE activities. It is AMCP’s intent that all CPE activities be independent, objective, balanced, evidence-based and free of any commercial bias.  

Method and CE Requirements:   

Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live symposium activity presented in conjunction with the AMCP Managed Care & Specialty Pharmacy Annual Meeting 2016.

CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor.  Please allow 24-72 hours for processing and posting in your NABP account.

Pharmacists interested in obtaining CPE credit must:

  1. View the entire pre-recorded audio/slide presentation.
  2. Successfully complete the post-test with a score of 70% or higher (The post-test may be taken up-to three times, and will provide feedback.)
  3. Complete a specific online activity evaluation. 
To receive CME and CNE credit you must complete steps 1 and 2. After watching the video in its entirety you will have access to the document entitled, "Physicians and Nurses" with instructions to follow.
PRIME Accreditation  

This activity is planned and implemented by PRIME® Education, Inc. and the Academy of Managed Care Pharmacy. PRIME® Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Physician Credit Designation Statement 
PRIME® designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit™. Physicians should claim only commensurate with the extent of their participation in the activity.  


Nurse Accreditation Statement 

PRIME® designates this activity for 2.0 contact hours.

System Technical Requirements/Viewing Requirements: 
System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities you should have a basic comfort level using a computer and navigating web sites.  View the minimum technical and system requirements for continuing education online learning activities.

All Faculty in this education session have obtained the appropriate permission to use Copy Righted materials. Sources for all images are provided in citations.

Statement of Commercial Support 

This activity is supported by an independent educational grant from Novo Nordisk.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE UAN #0233-9999-16-037-H01-P 2 Contact Hours April 21, 2016 - April 21, 2019